PRIMARY MYELOFIBROSIS (PMF)
Clinical trials for PRIMARY MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for PRIMARY MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested for rare blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of an experimental oral drug called PRT12396 for people with certain rare blood cancers. It will enroll about 100 adults with high-risk polycythemia vera or myelofibrosis. The main goal is to see how well t…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Last-Chance drug access for serious illnesses
Disease control AVAILABLEThis program provides access to the drug ruxolitinib for patients with serious conditions like certain blood cancers and severe graft-versus-host disease. It is for people who have no other treatment options and cannot join a standard clinical trial. The program allows doctors to…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study designed to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. for 5-10 years, collecting health records and patient surveys to track symptoms, treatm…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC